Advanced search
Publication Cover
ClinicoEconomics and Outcomes Research Volume 13, 2021 - Issue
Submit an article Journal homepage
118
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Obinutuzumab Plus Chemotherapy Compared with Rituximab Plus Chemotherapy in Previously Untreated Italian Patients with Advanced Follicular Lymphoma at Intermediate–High Risk: A Cost-Effectiveness Analysis

Marco Bellone1 Department of Health Economics and Outcome Research, AdRes Health Economics and Outcomes Research, Turin, ItalyCorrespondence[email protected]
View further author information
,
Lorenzo Pradelli1 Department of Health Economics and Outcome Research, AdRes Health Economics and Outcomes Research, Turin, ItalyORCID Iconhttps://orcid.org/0000-0002-7648-8917View further author information
ORCID Icon,
Stefano Molica2 Dipartimento Onco-ematologico, Azienda Ospedaliera Pugliese-Ciaccio, Catanzaro, ItalyView further author information
,
Adele Emanuela De Francesco3 Hospital Pharmacy, Mater Domini Azienda Ospedaliero Universitaria, Catanzaro, ItalyView further author information
,
Daniela Ghislieri4 Market Access Department, Roche SpA, Monza, ItalyView further author information
,
Emanuele Guardalben5 Medical Department, Roche SpA, Monza, ItalyView further author information
&
Antonietta Caputo4 Market Access Department, Roche SpA, Monza, ItalyView further author information
 show all
Pages 661-671 | Published online: 22 Jul 2021

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.